Clinical Trial Update: Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults [Phase 2]

View source ↗

Summary

Phase 2 trial update on immunogenicity, safety and tolerability of a plant-derived quadrivalent influenza vaccine in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rna Virus Infections
• Viral Respiratory Infection
• Virus Diseases

Drugs mentioned

• Plant-derived Quadrivalent Influenza Vaccine

Snippet

Sponsor: Medicago | Conditions: Virus Diseases, RNA Virus Infections | Phase 2 | Status: COMPLETED